Stock Scorer

Vivani Medical, Inc. (VANI)

Vivani Medical, Inc. reported revenue of 0 USD for the quarter ending 30 June 2025.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '25 · ending 30 June 2025 0 —
Gross Profit Q4 '21 · ending 31 December 2021 130K -65.1%
Operating Income Q2 '26 · ending 30 June 2026 -6.9M —
Net Income Q2 '26 · ending 30 June 2026 -6.4M —
Cost of Revenue Q2 '21 · ending 30 June 2021 0 -100.0%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -6M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -6.1M —
Shares Outstanding Q2 '26 · ending 30 June 2026 87.1M +47.0%
EPS Q2 '26 · ending 30 June 2026 -0.35 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 0-27.6M-26.6M-25.5M
20242024-12-31 0-24.7M-23.5M-21.3M
20192019-12-31 3.4M-34M-33.6M-28.1M
20182018-12-31 6.9M-35.2M-35.1M-30M
20172017-12-31 8M-28.6M-28.5M-24.2M
20162016-12-31 4M-33.2M-33.2M-25.6M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '252025-06-300
Q1 '252025-03-310
Q4 '242024-12-310
Q3 '242024-09-300
Q2 '212021-06-300
Q2 '202020-06-300
Q4 '192019-12-31497K
Q3 '192019-09-30472K
Q2 '192019-06-301.3M
Q1 '192019-03-311.1M
Q4 '182018-12-311.8M
Q3 '182018-09-302.2M
Q2 '182018-06-301.9M
Q1 '182018-03-31976K
Q4 '172017-12-313.1M
Q3 '172017-09-301.6M
Q2 '172017-06-302.2M
Q1 '172017-03-311M
Q1 '162016-03-311.1K
Q4 '152015-12-312.3M

Gross Profit Quarterly

PeriodEndingGross Profit
Q4 '212021-12-31130K
Q2 '212021-06-300
Q4 '202020-12-31500K
Q2 '202020-06-300
Q4 '192019-12-31373K
Q3 '192019-09-30108K
Q2 '192019-06-30349K
Q1 '192019-03-31397K
Q4 '182018-12-31167K
Q3 '182018-09-30462K
Q2 '182018-06-301.1M
Q1 '182018-03-31308K
Q4 '172017-12-311.2M
Q3 '172017-09-30609K
Q2 '172017-06-301.1M
Q1 '172017-03-31-118K
Q4 '162016-12-31-2.6M
Q3 '162016-09-30-1.4M
Q2 '162016-06-30-2.2M
Q1 '162016-03-31141K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-6.9M
Q1 '262026-03-31-6.8M
Q4 '252025-12-31-6.8M
Q3 '252025-09-30-6.7M
Q2 '252025-06-30-7.5M
Q1 '252025-03-31-6.6M
Q4 '242024-12-31-6.5M
Q3 '242024-09-30-6.3M
Q2 '242024-06-30-5.7M
Q1 '242024-03-31-6.2M
Q4 '232023-12-31-6.2M
Q3 '232023-09-30-7.1M
Q2 '232023-06-30-7M
Q1 '232023-03-31-6.6M
Q4 '222022-12-31-7.8M
Q3 '222022-09-30-5.4M
Q2 '222022-06-30-4.1M
Q1 '222022-03-31-3.9M
Q4 '212021-12-31-1.3M
Q3 '212021-09-30-3.5M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-6.4M
Q1 '262026-03-31-6.8M
Q4 '252025-12-31-6.6M
Q3 '252025-09-30-6.5M
Q2 '252025-06-30-7.1M
Q1 '252025-03-31-6.3M
Q4 '242024-12-31-6M
Q3 '242024-09-30-6M
Q2 '242024-06-30-5.4M
Q1 '242024-03-31-6M
Q4 '232023-12-31-6M
Q3 '232023-09-30-6.8M
Q2 '232023-06-30-6.5M
Q1 '232023-03-31-6.3M
Q4 '222022-12-31-7.3M
Q3 '222022-09-301.4M
Q2 '222022-06-30-4.1M
Q1 '222022-03-31-3.9M
Q4 '212021-12-31-1.3M
Q3 '212021-09-30-3.5M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '212021-06-300
Q2 '202020-06-300
Q4 '192019-12-31124K
Q3 '192019-09-30364K
Q2 '192019-06-30933K
Q1 '192019-03-31731K
Q4 '182018-12-311.6M
Q3 '182018-09-301.8M
Q2 '182018-06-30836K
Q1 '182018-03-31668K
Q4 '172017-12-311.9M
Q3 '172017-09-301M
Q2 '172017-06-301.1M
Q1 '172017-03-311.1M
Q1 '162016-03-31912
Q4 '152015-12-311.7M
Q3 '152015-09-30757.1K
Q2 '152015-06-301.6M
Q1 '152015-03-311.3K
Q4 '142014-12-311.4M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-6M
Q1 '262026-03-31-6.2M
Q4 '252025-12-31-6.7M
Q3 '252025-09-30-6.4M
Q2 '252025-06-30-6.1M
Q1 '252025-03-31-5.2M
Q4 '242024-12-31-5.8M
Q3 '242024-09-30-5.7M
Q2 '242024-06-30-4.8M
Q1 '242024-03-31-4.5M
Q4 '232023-12-31-3.5M
Q3 '232023-09-30-7.7M
Q2 '232023-06-30-5.5M
Q1 '232023-03-31-7M
Q4 '222022-12-31-5.2M
Q3 '222022-09-30-7M
Q2 '222022-06-30-3.4M
Q1 '222022-03-31-3.2M
Q4 '212021-12-31-3M
Q3 '212021-09-30-3M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-6.1M
Q1 '262026-03-31-6.2M
Q4 '252025-12-31-7M
Q3 '252025-09-30-7.2M
Q2 '252025-06-30-6.2M
Q1 '252025-03-31-5.2M
Q4 '242024-12-31-6.1M
Q3 '242024-09-30-5.7M
Q2 '242024-06-30-4.8M
Q1 '242024-03-31-4.7M
Q4 '232023-12-31-4.2M
Q3 '232023-09-30-7.8M
Q2 '232023-06-30-5.6M
Q1 '232023-03-31-7M
Q4 '222022-12-31-5.3M
Q3 '222022-09-30-7.1M
Q2 '222022-06-30-3.5M
Q1 '222022-03-31-3.2M
Q4 '212021-12-31-3.2M
Q4 '202020-12-31-1.5M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3087.1M
Q1 '262026-03-3181.3M
Q3 '252025-09-3059.7M
Q2 '252025-06-3059.2M
Q1 '252025-03-3159.2M
Q3 '242024-09-3055.2M
Q2 '242024-06-3055M
Q1 '242024-03-3152.2M
Q3 '232023-09-3050.8M
Q2 '232023-06-3050.8M
Q1 '232023-03-3150.8K
Q3 '222022-09-3038.5K
Q2 '222022-06-3036.9K
Q1 '222022-03-3136.8K
Q3 '212021-09-3033.8K

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-0.35
Q1 '262026-03-31-0.40
Q4 '252025-12-31-0.43
Q3 '252025-09-30-0.45
Q2 '252025-06-30-0.45
Q1 '252025-03-31-0.43
Q4 '242024-12-31-0.44
Q3 '242024-09-30-0.44
Q2 '242024-06-30-0.46
Q1 '242024-03-31-0.49
Q2 '212021-06-30-0.33
Q1 '212021-03-31-0.40
Q4 '202020-12-31-0.85
Q3 '202020-09-30-1.29
Q2 '202020-06-30-1.71
Q1 '202020-03-31-2.12
Q4 '192019-12-31-2.35
Q3 '192019-09-30-2.81
Q2 '192019-06-30-2.44
Q1 '192019-03-31-2.00